Target intelligence / Profile preview

3',5'-cyclic phosphodiesterase 3A (PDE3A)

Target
PDE3A
Molecular classification
Enzyme, cGMP-inhibited cyclic nucleotide phosphodiesterase (cGI-PDE)
01

Overview

PDE3A is a member of the cGMP-inhibited cyclic nucleotide phosphodiesterase (cGI-PDE) family. It is an enzyme that hydrolyzes both cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are key second messengers involved in regulating numerous physiological processes. PDE3A plays a critical role in regulation of cardiac muscle contractility, vascular smooth muscle contraction, and platelet aggregation. It is also an emerging target for cancer therapy, with certain compounds inducing apoptosis specifically in cancer cells overexpressing PDE3A.

02

Mechanism of action

Catalyzes the breakdown of cAMP/cGMP to their inactive forms. In oncology, some ligands act as molecular glues inducing protein-protein interactions, leading to apoptosis in cancer cells.

03

Biological functions

Regulation of cardiac muscle contractilityVascular smooth muscle contractionPlatelet aggregationHydrolyzes cAMPHydrolyzes cGMP
04

Disease associations

Heart failureCancerGastrointestinal stromal tumors (GIST)
05

Safety considerations

Arrhythmic side effects (Milrinone)Increased mortality risk in some settings (Milrinone)
06

Interacting drugs

Milrinone

5 more in the full profile.

Beyond the preview

Go deeper on 3',5'-cyclic phosphodiesterase 3A (PDE3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3',5'-cyclic phosphodiesterase 3A (PDE3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call